MedTrace Logo

Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal Women

NCT07757724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2026-08-11

No results posted yet for this study

Summary

Many women sleep poorly during the menopausal transition. Some prefer not to take hormone therapy or sleeping tablets, and ask their nurses about other options. This study tested a traditional Chinese medicine aromatic sachet containing ten herbs, chosen by a panel of experts. Women placed the sachet beside their pillow each night for nine weeks and removed it each morning.

One hundred and twenty-two women aged 45 to 59 who reported poor sleep and were recruited in Macao took part. Half received the herbal sachet and half received a placebo sachet, which was identical in appearance, weight and packaging and carried a herbal scent, but did not contain the herbs being tested. Participants were not told which sachet they had been given. Sleep quality was measured using the Pittsburgh Sleep Quality Index at the start of the study and again after 3, 6 and 9 weeks.

Conditions

  • Sleep Initiation and Maintenance Disorders
  • Menopause

Interventions

OTHER

Traditional Chinese medicine aromatic sachet

Aromatic sachet containing Albizia flower 12 g, lavender 12 g, Acorus 5 g, rose 12 g, white chrysanthemum 12 g, Atractylodes 12 g, Angelica 12 g, mugwort 12 g, chuanxiong 7 g and cinnamon twig 7 g, 103 g total. Used nightly beside the pillow for nine weeks and replaced every three weeks.

OTHER

Placebo aromatic sachet

Odour-plausible placebo sachet containing Agastache rugosa, Angelica dahurica, Pueraria montana var. lobata, Plantago asiatica, pumice and Hibiscus sabdariffa, matched to the active sachet in appearance, weight and packaging. Used nightly beside the pillow for nine weeks and replaced every three weeks.

Sponsors & Collaborators

  • Macao Polytechnic University

    lead OTHER

Principal Investigators

  • Cindy SIN U LEONG, DHSc, MHS, BSN, RN · Macao Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Macau

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07757724 on ClinicalTrials.gov